Titin-related Cardiomyopathy: Is it a Distinct Disease? Celine F. SantiagoInken G. HuttnerDiane Fatkin Myocardial Disease (A Abbate and M Merlo, Section Editors) 27 June 2022 Pages: 1069 - 1075
Emerging Genotype–Phenotype Associations in Dilated Cardiomyopathy Joyce N. NjorogeJennifer C. MangenaVictoria N. Parikh Myocardial Disease (A Abbate and M Merlo, Section Editors) 28 July 2022 Pages: 1077 - 1084
Cardiovascular Damage in COVID-19: What We Know Two Years Later Vincenzo NuzziEva Del MestreAntonio Cannata Myocardial Disease (A Abbate and M Merlo, Section Editors) Open access 25 June 2022 Pages: 1085 - 1091
Keto is Trending: Implications for Body Weight and Lipid Management Carol F. KirkpatrickKaye-Eileen WillardKevin C. Maki Lipid Abnormalities and Cardiovascular Prevention (ED Michos, Section Editor) 06 July 2022 Pages: 1093 - 1100
SAMSON and the Nocebo Effect: Management of Statin Intolerance Amrita KrishnamurthyCorey BradleySamuel M. Kim Lipid Abnormalities and Cardiovascular Prevention (ED Michos, Section Editor) 27 June 2022 Pages: 1101 - 1108
Advanced Echocardiographic Techniques in Cardio-Oncology: the Role for Early Detection of Cardiotoxicity Lucía Cobarro GálvezEmilio Arbas RedondoTeresa López Fernández Cardio-Oncology (LA Baldassarre, Section Editor) 26 July 2022 Pages: 1109 - 1116
Disparities in Cardio-oncology: Effects On Outcomes and Opportunities for Improvement Javaria AhmadAnjani MuthyalaSarju Ganatra Cardio-Oncology (LA Baldassarre, Section Editor) 27 June 2022 Pages: 1117 - 1127
Health Disparities Across the Continuum of ASCVD Risk Ankita DevareddyAshish SarrajuFatima Rodriguez Global Cardiovascular Health (L Sperling and D Gaita, Section Editors) 05 July 2022 Pages: 1129 - 1137
Aspirin for Primary Prevention of Cardiovascular Diseases: “WALTZ” with the Evidence Kyriakos DimitriadisEmilia LazarouKonstantinos Tsioufis Global Cardiovascular Health (L Sperling and D Gaita, Section Editors) 20 July 2022 Pages: 1139 - 1147
HIV and Global Cardiovascular Health Anjali WagleErin GoerlichAllison G. Hays Global Cardiovascular Health (L Sperling and D Gaita, Section Editors) 08 July 2022 Pages: 1149 - 1157
Closed-Loop Artificial Pancreas Therapy for Type 1 Diabetes Keren ZhouDiana Isaacs Diabetes and Cardiovascular Disease (D Bruemmer, Section Editor) 21 June 2022 Pages: 1159 - 1167
Use of Polygenic Risk Scores for Coronary Heart Disease in Ancestrally Diverse Populations Ozan DikilitasDaniel J. SchaidIftikhar J. Kullo Cardiovascular Genomics (KG Aragam, Section Editor) 07 July 2022 Pages: 1169 - 1177
Update on Minimalist TAVR Care Pathways: Approaches to Care in 2022 Mariem A. SawanAvery E. CalhounChandan M. Devireddy Valvular Heart Disease (TL Kiefer, Section Editor) 29 June 2022 Pages: 1179 - 1187
Update on the Genetics of Primary Aldosteronism and Aldosterone-Producing Adenomas Georgia PitsavaFabio R. FauczFady Hannah-Shmouni Hypertension (DS Geller and DL Cohen, Section Editors) 16 July 2022 Pages: 1189 - 1195
Racial Disparities in Cardiovascular Risk and Cardiovascular Care in Women Rachel-Maria BrownSamia TamaziJennifer H. Mieres Women and Cardiovascular Health (N Goldberg and S Lewis, Section Editors) 08 July 2022 Pages: 1197 - 1208
Tricuspid Valve Percutaneous Therapies Bhaskar BhardwajJoaquin E. CigarroaFiras Zahr Interventional Cardiology (SR Bailey and T Helmy, Section Editor) 29 June 2022 Pages: 1209 - 1226